[go: up one dir, main page]

HK1168030A - Methods for treating brain tumors - Google Patents

Methods for treating brain tumors Download PDF

Info

Publication number
HK1168030A
HK1168030A HK12108729.7A HK12108729A HK1168030A HK 1168030 A HK1168030 A HK 1168030A HK 12108729 A HK12108729 A HK 12108729A HK 1168030 A HK1168030 A HK 1168030A
Authority
HK
Hong Kong
Prior art keywords
methods
brain tumors
treating brain
administering
alone
Prior art date
Application number
HK12108729.7A
Other languages
Chinese (zh)
Inventor
Yong Joon Jo
Yong-Jin Yang
Original Assignee
Kominox, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kominox, Inc. filed Critical Kominox, Inc.
Publication of HK1168030A publication Critical patent/HK1168030A/en

Links

Abstract

The present invention relates to methods treating brain tumors comprising administering a subject in need thereof a therapeutically effective amount of sodium meta arsenite, alone or in combination with another anti-brain tumor medicament.
HK12108729.7A 2009-09-18 2010-09-09 Methods for treating brain tumors HK1168030A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61/243,648 2009-09-18

Publications (1)

Publication Number Publication Date
HK1168030A true HK1168030A (en) 2012-12-21

Family

ID=

Similar Documents

Publication Publication Date Title
WO2012062925A3 (en) Compounds and methods for treating pain
WO2011034775A3 (en) Methods for treating brain tumors
IL260560B (en) A sulfonyl-amino pyrimidinyl-amino benzamide compound for use as a medicament in a method for the treatment of cancer in a mammal
WO2011022440A3 (en) Heat shock protein binding compounds, compositions, and methods for making and using same
WO2012038504A3 (en) Breast cancer therapeutics
PT2139483E (en) Combination therapies comprising a quinoxaline inhibitor of pi3k-alpha for use in the treatment of cancer
WO2012149478A3 (en) Agents useful for treating friedreich's ataxia and other neurodegenerative diseases
EP2582682A4 (en) Methods of treating lung disease
WO2012006421A3 (en) Diagnosis and treatment of breast cancer
IN2014DN08886A (en)
HK1204578A1 (en) Medicament for the treatment of acute myeloid leukemia (aml)
MX2020010004A (en) Therapeutic uses of empagliflozin.
WO2009142738A3 (en) Compositions and methods for diagnosing and treating cancer
WO2013098416A3 (en) Pain relief compounds
HK1214552A1 (en) Treatment of cancer with pomalidomide in a renally impaired subject
WO2018102261A3 (en) Boronic derivatives hydroxamates as anticancer agents
WO2007022408A3 (en) Combination methods of saha and targretin for treating cancer
WO2010036567A3 (en) Harmine compounds for promoting bone growth
WO2014032019A3 (en) Compounds and methods for treating tumors
WO2010039187A3 (en) Fused diimidazodiazepine compounds and methods of use and manufacture thereof
WO2011031890A3 (en) Cancer stem cell-targeted and drug resistant cancer therapy
TW201129361A (en) Methods for treating pain
PH12015501113A1 (en) Combination therapy with volasertib
WO2009088992A3 (en) Ribonuclease and thiazolidinedione compounds and their use in methods to treat cancer
WO2012153253A3 (en) Aromatic compounds and metal complexes thereof